A Prescription for Fair Drug Pricing

instituteforclinicalandeconomicreview•instituteforclinicalandeconomicreview.podbean.com

By Jason L. Crowell, MD Jerome H. Grossman MD Graduate Fellow, Harvard Kennedy School Neurologist, Beth Israel Deaconess Medical Center; Steve Pearson, Founder and President, ICER, Lecturer, Department of Population Medicine, Harvard Medical School

Last refreshed: June 27th, 2025 at 2:15 PM ⓘ

Follow this podcast in the Metacast mobile app to refresh it and see new episodes.

Follow on

Apple Podcasts

Spotify

RSS

Podcasts are better in Metacast mobile app

Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episodes

How doctors can be a part of the solution

What can physicians do in their hospitals and communities to advocate for fair drug prices? What questions should we ask our patients to assess for financial toxicity? In the final episode of the season, we discuss the steps doctors can be taking now to help solve the drug pricing problem.

Dec 21, 2020•16 min•Season 1Ep. 8

What else makes a drug “valuable”?

If we only look at the benefits that a drug provides to those patients who take it, we may underestimate its value by ignoring the benefits it provides to the broader healthcare system. In episode 7, we reveal some of the other reasons that can make a drug more valuable than first meets the eye.

Dec 14, 2020•20 min•Season 1Ep. 7

Cost-effectiveness 101

If a “fair” price rewards the benefit a drug provides, how do we quantify those benefits—both to the patient and, more broadly, to society? Cost-effectiveness analysis is the tool we can use to quantify a drug’s benefit in a way that can be compared across treatments.

Dec 07, 2020•26 min•Ep. 6

Who sets a drug’s price, and how do we know it’s fair?

In episode 5, we review the variety of approaches one might take to settle on what the “fair” price of a drug should be. The most logical solution to this problem is to price the value—set a drug’s price commensurate with the clinical benefits it provides.

Nov 30, 2020•22 min•Season 1Ep. 5

What’s in it for me? Incentives for making new drugs

What motivates a drug manufacturer to create a drug in the first place? How do firms stretch the limits of these incentives? In episode 4, we discuss how the “ecosystem” of drug development in the US has led to truly remarkable innovation but also runaway drug prices.

Nov 23, 2020•27 min•Ep. 4

From Pharma to the Medicine Cabinet: Who Manages the Drugs?

Drugmakers, pharmacies, wholesale distributors, physicians, pharmacy benefit managers—the world of prescription drugs can seem extraordinarily complex. In episode 3, we disentangle this spider’s web and answer the question: who decides how much our patients pay at the pharmacy?

Nov 16, 2020•25 min•Ep. 3

Tradeoffs

Whenever we choose to spend on one thing instead of another, we pay an opportunity cost. And, just like in life, healthcare is an either/or decision. Patients face decisions about how to spend their money on healthcare, just like insurance companies and governments must decide how to spend their finite dollars on healthcare.

Nov 09, 2020•15 min•Season 1Ep. 2

Financial Toxicity

In the first episode of the series, we discuss the problem of skyrocketing drug prices and the harmful effects they have on our patients. Not only must patients decide what their medications are worth to them, but payers introduce barriers that limit patients’ access to care. More broadly, we also review the ways that drug prices affect all of our society, via rising insurance premiums and taxes.

Nov 02, 2020•17 min•Season 1Ep. 1

COMING SOON: A Prescription for Fair Drug Pricing

In a new podcast series from the Institute for Clinical and Economic Review (ICER), neurologist Dr. Jason Crowell sits down with ICER’s President Dr. Steve Pearson to pry open the black box of US drug pricing and to wrestle with each of the financial and ethical tensions that undergird our current medical infrastructure. A must-listen for physicians, patients, and policymakers who are concerned that prescription drugs not only can have health side effects, but financial side effects, too.

Oct 15, 2020•4 min

For the best experience, listen in Metacast app for iOS or Android